BUPLANT

Welcome to the Brand page for “BUPLANT”, which is offered here for Pharmaceuticals, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases;.

Its status is currently believed to be active. Its class is unavailable. “BUPLANT” is believed to be currently owned by “TITAN PHARMACEUTICALS, INC.”